Literature DB >> 33360637

Independent effects of entering recovery as a young versus older adult on long-term functioning and quality of life: Results from a U.S. national study of recovering persons.

John F Kelly1, M Claire Greene2, Alexandra Abry3, Brandon G Bergman3.   

Abstract

BACKGROUND: For physical health conditions, earlier intervention typically results in better prognoses and improved quality of life (QoL). Despite some evidence that early intervention yields better subsequent functioning too for behavioral health conditions like alcohol and other drug (AOD) disorders, less is known. This study examined the relationship between the life-stage at which individuals entered AOD recovery, demographic and clinical correlates, and its relationship to a variety of indices of current functioning, QoL and well-being.
METHOD: Nationally representative sample of U.S. adults who resolved an AOD problem (Weighted N = 1844). Structured regression analyses tested whether life-stage at which individuals entered recovery (i.e., as a young [18-30yrs,n = 746] vs. older [>30yrs,n = 1098] adult), was associated with current QoL, happiness, self-esteem, distress, and recovery capital, independent of confounders. Sensitivity analyses investigated effects during the first 5-years of recovery.
RESULTS: Young adult recovery entry was independently associated with current employment, younger age of onset for primary substance, primary substance other than alcohol, and less lifetime psychiatric comorbidity. In fully-adjusted models examining indices of functioning, no association was found between life-stage at recovery entry and current self-esteem, happiness, or distress, but an association was found between young adult recovery entry and better current functioning and QoL. This effect was even more pronounced during the first 5-years of recovery.
CONCLUSION: Irrespective of current age, duration of recovery, and clinical markers of impairment, entering recovery as a young, versus older, adult, is associated with better subsequent QoL - an advantage that appears even more discernable early in recovery.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Development; Emerging adults; Epidemiology; Functioning; National; Quality of life; Recovery; Remission; Young adulthood; Young adults

Mesh:

Year:  2020        PMID: 33360637      PMCID: PMC7855819          DOI: 10.1016/j.drugalcdep.2020.108493

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  29 in total

1.  Screening for serious mental illness in the general population.

Authors:  Ronald C Kessler; Peggy R Barker; Lisa J Colpe; Joan F Epstein; Joseph C Gfroerer; Eva Hiripi; Mary J Howes; Sharon-Lise T Normand; Ronald W Manderscheid; Ellen E Walters; Alan M Zaslavsky
Journal:  Arch Gen Psychiatry       Date:  2003-02

2.  Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement.

Authors:  Albert L Siu
Journal:  Ann Intern Med       Date:  2015-10-27       Impact factor: 25.391

3.  The EUROHIS-QOL 8-item index: psychometric results of a cross-cultural field study.

Authors:  Silke Schmidt; Holger Mühlan; Mick Power
Journal:  Eur J Public Health       Date:  2005-09-01       Impact factor: 3.367

4.  Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors:  Ali H Mokdad; Mohammad Hossein Forouzanfar; Farah Daoud; Arwa A Mokdad; Charbel El Bcheraoui; Maziar Moradi-Lakeh; Hmwe Hmwe Kyu; Ryan M Barber; Joseph Wagner; Kelly Cercy; Hannah Kravitz; Megan Coggeshall; Adrienne Chew; Kevin F O'Rourke; Caitlyn Steiner; Marwa Tuffaha; Raghid Charara; Essam Abdullah Al-Ghamdi; Yaser Adi; Rima A Afifi; Hanan Alahmadi; Fadia AlBuhairan; Nicholas Allen; Mohammad AlMazroa; Abdulwahab A Al-Nehmi; Zulfa AlRayess; Monika Arora; Peter Azzopardi; Carmen Barroso; Mohammed Basulaiman; Zulfiqar A Bhutta; Chris Bonell; Cecilia Breinbauer; Louisa Degenhardt; Donna Denno; Jing Fang; Adesegun Fatusi; Andrea B Feigl; Ritsuko Kakuma; Nadim Karam; Elissa Kennedy; Tawfik A M Khoja; Fadi Maalouf; Carla Makhlouf Obermeyer; Amitabh Mattoo; Terry McGovern; Ziad A Memish; George A Mensah; Vikram Patel; Suzanne Petroni; Nicola Reavley; Diego Rios Zertuche; Mohammad Saeedi; John Santelli; Susan M Sawyer; Fred Ssewamala; Kikelomo Taiwo; Muhammad Tantawy; Russell M Viner; Jane Waldfogel; Maria Paola Zuñiga; Mohsen Naghavi; Haidong Wang; Theo Vos; Alan D Lopez; Abdullah A Al Rabeeah; George C Patton; Christopher J L Murray
Journal:  Lancet       Date:  2016-05-09       Impact factor: 79.321

5.  Long-term influence of duration and intensity of treatment on previously untreated individuals with alcohol use disorders.

Authors:  Rudolf H Moos; Bernice S Moos
Journal:  Addiction       Date:  2003-03       Impact factor: 6.526

Review 6.  Pediatric Hypertension: Diagnosis, Evaluation, and Treatment.

Authors:  Monica Guzman-Limon; Joshua Samuels
Journal:  Pediatr Clin North Am       Date:  2019-02       Impact factor: 3.278

7.  Testing the drug substitution switching-addictions hypothesis. A prospective study in a nationally representative sample.

Authors:  Carlos Blanco; Mayumi Okuda; Shuai Wang; Shang-Min Liu; Mark Olfson
Journal:  JAMA Psychiatry       Date:  2014-11       Impact factor: 21.596

8.  Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy.

Authors:  John F Kelly; Brandon Bergman; Bettina B Hoeppner; Corrie Vilsaint; William L White
Journal:  Drug Alcohol Depend       Date:  2017-10-18       Impact factor: 4.492

9.  Psychopathology as a predictor of treatment outcome in alcoholics.

Authors:  B J Rounsaville; Z S Dolinsky; T F Babor; R E Meyer
Journal:  Arch Gen Psychiatry       Date:  1987-06

10.  Beyond Abstinence: Changes in Indices of Quality of Life with Time in Recovery in a Nationally Representative Sample of U.S. Adults.

Authors:  John F Kelly; M Claire Greene; Brandon G Bergman
Journal:  Alcohol Clin Exp Res       Date:  2018-02-23       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.